Revenue - Narrative (Details) - USD ($) |
9 Months Ended | ||
|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Disaggregation of Revenue [Line Items] | |||
| Amount of revenue for remaining performance obligations | $ 166,000,000 | ||
| Impairment losses | $ 0 | $ 0 | |
| Revenue Benchmark | Customer Concentration Risk | U.S. Government | |||
| Disaggregation of Revenue [Line Items] | |||
| Concentration risk, percentage | 7.00% | 7.00% | |
| Revenue Benchmark | Customer Concentration Risk | Transferred Over Time | |||
| Disaggregation of Revenue [Line Items] | |||
| Concentration risk, percentage | 9.00% | 9.00% | |
| X | ||||||||||
- Definition Contract With Customer, Asset, Impairment Loss No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|